Discussion
In this case tophi were presented as nodules at the distal interphalangeal joints, dorsal aspect of the proximal interphalangeal and metacarpophalangeal joints and toes. They arised in a postmenopausal woman (as they usually do, because of the absence of the protective effect of estrogen on acid uric level), with no previous signs of gout. Tophi had a progressive evolution over a few months, with a spontaneous drainage and a subsequent ulceration on the toe. Among the risk factors for gout, in this case, we could not include: alcohol intake, use of thiazide diuretics, renal dysfunction or hypertension; but we thought of Infliximab as a risk factor [2] . The differential diagnosis included calcium pyrophosphate deposition disease (pseudogout), calcinosis cutis, and rheumatoid or cholesterol nodules [3, 4] , but the diagnosis of gout was strongly considered on the clinical, histopathological grounds corelared with the hiperuricemia. The risk of gout increases with increasing hyperuricemia, although serum uric acid levels may be elevated without clinical evidence of gout [3] . Although many medications also favor this condition, such as low-dose aspirin, cyclosporine, ethambutol, pyrazinamide, ritonavir, levodopa, and nicotinic acid [4] , we consider that it is the first case reported in the literature as gout induced by Infliximab in a patient with Rheumatoid Arthritis, taking into considerations that Infliximab is a therapy of choise in chronic tophaceous gout [5] . 
